Treatment for Bipolar Disorder with Increased Anxiety
For patients with bipolar disorder and increased anxiety, a combination of mood stabilizers and atypical antipsychotics is the primary treatment approach, with lamotrigine being particularly beneficial for those with predominant depressive symptoms and anxiety. 1, 2
First-Line Pharmacotherapy Options
Mood Stabilizers
Lithium: FDA-approved for ages 12+ for acute mania and maintenance therapy 1
- Most evidence for prophylaxis of episodes compared to other agents 3
- Effective for mania but less effective for preventing depression
- Requires regular monitoring of serum levels, thyroid and renal function
Valproate: Effective for acute mania with response rates of 53% 1
- Particularly useful for rapid cycling and mixed episodes
- Requires monitoring of liver function, complete blood counts, and pregnancy tests
- Caution regarding polycystic ovary disease risk in females 1
Lamotrigine: Particularly effective for bipolar depression and anxiety 2, 4
Atypical Antipsychotics
- Quetiapine, Olanzapine, Risperidone, Aripiprazole: All FDA-approved for acute mania in adults 1
Treatment Algorithm for Bipolar with Anxiety
Initial Treatment:
Inadequate Response:
For Persistent Anxiety:
Important Cautions
Avoid antidepressant monotherapy: Not recommended as they may destabilize mood or precipitate manic episodes 1, 2, 6
Monitor for metabolic effects: Atypical antipsychotics are associated with significant weight gain and metabolic problems 1
- Baseline body mass index, waist circumference, blood pressure, fasting glucose, and lipid panel recommended
- Follow body mass index monthly for 3 months then quarterly
- Monitor blood pressure, glucose, and lipids after 3 months and then yearly
Long-Term Considerations
- Most patients will require ongoing medication therapy to prevent relapse; some individuals will need lifelong treatment 1
- More than 80% of patients with a manic episode will have at least one episode of relapse 1
- Withdrawal of maintenance therapy is associated with increased risk of relapse 1
- Life expectancy is reduced by approximately 12-14 years in people with bipolar disorder 6
- Medication regimen needed to stabilize acute symptoms should be maintained for 12-24 months 1
Special Considerations for Comorbidities
- For comorbid ADHD: Add stimulants only after mood symptoms are adequately controlled on a mood stabilizer 1
- For comorbid substance abuse: Lithium has demonstrated benefit 1
- Comorbid anxiety is associated with poor treatment responses, substance abuse, and disability 4
By following this structured approach to treating bipolar disorder with anxiety, clinicians can optimize outcomes while minimizing risks of mood destabilization and side effects.